Science

May 6, 2025, 16:09

Myeloma Paper of the Day, May 6th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Extramedullary disease (PFS was 24.2 months without EMD vs. 9.0 months with) but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in myeloma; about half of relapses post-CAR T had EMD.”

Title: Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma

Authors: Darren Pan, Tarek H. Mouhieddine, Tianxiang Sheng, Weijia Fu, Erin Moshier, Joshua Richter, Samir Parekh, Sundar Jagannath, Adriana C. Rossi, Larysa J. Sanchez, Santiago Thibaud, Cesar Rodriguez, Hearn J. Cho and Shambavi Richard.

Read the Full Article on Bone Marrow Transplantation.

More posts featuring Robert Orlowski.

Adriana C. Rossi Bone Marrow Transplantation cancer CAR T-cell therapy Cesar Rodriguez Darren Pan Erin Moshier Hearn J. Cho Joshua Richter Larysa J. Sanchez multiple myeloma Myeloma Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Samir Parekh Santiago Thibaud Shambavi Richard Sundar Jagannath Tarek H. Mouhieddine Tianxiang Sheng Weijia Fu

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth